Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN & C3G
  - Search for:
- Neurology
  - BACK
  - Neurology
  - Alzheimer's Disease
  - Epilepsy
  - Insomnia
  - Migraine
  - Multiple Sclerosis
  - Tuberous Sclerosis Complex
  - Search for:
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Search for:
Conference Reporter
Conference Calendar
Expert Directory
About Expert Perspectives
Login/Register
Search for:

Neurology

Multiple Sclerosis

Advertisment

Quality-of-Life Determinants in Multiple Sclerosis: Pearls From Practice

Multiple Sclerosis

Quality-of-Life Determinants in Multiple Sclerosis: Pearls From Practice

patient care perspectives
By Malcolm H. Gottesman, MD

Elderly Patients With Multiple Sclerosis: Efficacy of Disease-Modifying Therapy

Multiple Sclerosis

Elderly Patients With Multiple Sclerosis: Efficacy of Disease-Modifying Therapy

patient care perspectives
By Malcolm H. Gottesman, MD

Imaging and Nonimaging Biomarkers in Multiple Sclerosis

Multiple Sclerosis

Imaging and Nonimaging Biomarkers in Multiple Sclerosis

clinical topic updates
By Robert A. Bermel, MD, MBA

Newer Disease-Modifying Therapies for Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis

Newer Disease-Modifying Therapies for Relapsing Forms of Multiple Sclerosis

clinical topic updates
By Malcolm H. Gottesman, MD

Clinical Trials Leading to Advancements in Multiple Sclerosis

Multiple Sclerosis

Clinical Trials Leading to Advancements in Multiple Sclerosis

expert roundtables
By Eric C. Klawiter, MD, MSc; Malcolm H. Gottesman, MD; Robert A. Bermel, MD, MBA

Load More

Experts in Multiple Sclerosis

+6

Meet the Experts

Advertisment

2024 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

By submitting a new user registration you’re agreeing to the Privacy Policy and Terms of Service for Expert Perspectives in Medicine and its subsidiaries.